Tomas G Olsson
1 – 10 of 50
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
- Increased basal ganglia binding of 18F-AV-1451 in patients with progressive supranuclear palsy
- Modeling strategies for quantification of in vivo 18F-AV1451 binding in patients with tau pathology
- 2015
- Role of CD8-positive cells in radioimmunotherapy utilizing (177)Lu-mAbs in an immunocompetent rat colon carcinoma model.
- Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model.
- 2014
- Change in Cell Death Markers During (177)Lu-mAb Radioimmunotherapy-Induced Rejection of Syngeneic Rat Colon Carcinoma.
- (18)F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.
- Sequential Radioimmunotherapy with (177)Lu- and (211)At-Labeled Monoclonal Antibody BR96 in a Syngeneic Rat Colon Carcinoma Model.
- 2013
- A niobium water target for routine production of [(18)F]Fluoride with a MC 17 cyclotron.
- The Intratumoral Distribution of Radiolabeled 177Lu-BR96 Monoclonal Antibodies Changes in Relation to Tumor Histology over Time in a Syngeneic Rat Colon Carcinoma Model.